UCL GBSH Student of the Week: Dr Sandeep Sinde

What inspired you to choose your Master’s programme at UCL GBSH? 

Being a medical doctor myself, I realised during my clinical internship that I could create a far larger impact on patient lives by improving access to medications, influencing policy changes, and shaping strategic decision-making, rather than remaining solely at the bedside. 

Daily ward rounds exposed me to the stark realities of treatment delays caused by supply chain failures, poor market access and misaligned commercial priorities, problems that no amount of individual clinical excellence could solve. This realisation drove me to seek a programme that would equip me to work at the intersection of medicine, business and policy. 

The MSc in Biotechnology and Pharmaceutical Management at UCL GBSH was exactly what I was looking for. It perfectly bridges clinical science with the commercial realities of drug development, market access, supply chain operations, and digital health innovation.

I had been searching for either this specialised healthcare management programme or pure business school MBAs, but UCL GBSH offered the ideal balance – rigorous pharma/biotech content taught from a strategic business perspective 

Which skills have you gained here that you believe will make the biggest difference in your career? 

Critical thinking is the key skill I’ve developed through this course. The modules are designed to make you actually think about the subject areas and reflect upon them, especially during the group seminars where we’re challenged to analyse and debate real scenarios from different angles. 

Teamwork, communication and collaboration are another important skillset I’ve gained during group presentations and group projects. My peers come from different backgrounds and I’ve learnt that everyone has a unique way of working. Navigating these differences to deliver cohesive group outputs has enhanced my ability to collaborate effectively across diverse teams. 

Working on projects has also significantly strengthened my research skills. From framing questions and gathering data to synthesising findings for presentations, I’ve gained confidence in conducting thorough, structured research that supports strategic recommendations. 

How has the programme’s structure supported your lifestyle and learning? 

I think the programme’s structure is just right. The lectures and seminars are scheduled at optimal times, leaving us with enough free time to properly explore London, attend career events, fun activities, society meetings and socialise with peers. This balance has been perfect for my lifestyle as an international student 

What professional opportunities have been most valuable to you? 

The professional opportunities that have been most valuable to me was our group assignment analysing the demerger of Johnson & Johnson and Kenvue. This project required us to evaluate the strategic, financial, and operational implications of separating a global healthcare conglomerate into two distinct entities. It strengthened my ability to assess corporate restructuring from both a strategic and shareholder-value perspective and helped me understand how large pharmaceutical organisations position themselves for long-term competitiveness. 

The industrial visit to GSK was equally impactful. Seeing the operational scale, regulatory frameworks and innovation processes within a leading pharmaceutical company provided practical insight into the industry I aspire to work in. It allowed me to connect classroom concepts with real-world execution, particularly in areas such as R&D strategy, pipeline management and global operations. 

Participating in the hackathon was another defining experience. Working under strict time constraints to solve a complex business case pushed me to think critically, structure problems efficiently, and make evidence-based decisions quickly. Competing alongside my peers fostered resilience and sharpened my ability to communicate strategic ideas clearly within a team setting. 

The guest lectures throughout the programme have also been highly valuable. Industry professionals shared real-world case scenarios that illustrated the practical challenges faced by biotech and pharmaceutical firms. These sessions gave me a realistic understanding of market access, commercialisation strategy and leadership decision-making beyond theoretical frameworks. 

Finally, the Term 1 assignment in the Biotech Policy and Practices module, which focused on a pharmaceutical company partnering with an AI firm, significantly shaped my thinking. It highlighted how strategic partnerships are critical mechanisms for value creation in the modern biotech ecosystem. This assignment encouraged me to evaluate collaborations not just scientifically, but from a commercial and strategic business perspective. 

What support has made a meaningful difference during your studies? 

The support that has made the most meaningful difference during my studies has been the career and academic guidance available to me. 

UCL’s central Careers Service has been particularly impactful. The advisers provided detailed and practical feedback on my CV, helping me refine how I present my academic background and professional experiences in a way that aligns with industry expectations. Their structured guidance on applications, assessment centres and interview preparation significantly improved my confidence and clarity when applying for roles. 

In addition, the dedicated Health Careers support at UCL East has been extremely valuable. The team offered tailored advice specific to the healthcare, biotech and pharmaceutical sectors, helping me better understand industry pathways and identify relevant opportunities. Their guidance on navigating sector-specific roles and building a targeted job search strategy has been instrumental in shaping my career direction. 

My personal tutor has also played an important role throughout my programme. Their academic guidance, regular check-ins and encouragement have helped me stay focused and reflective about my progress. Having a consistent point of contact for advice and mentorship has made a meaningful difference to both my academic performance and overall development. 

What has it been like studying within such a global and diverse cohort? 

Studying within such a global and diverse cohort has been an incredibly enriching experience. Throughout the programme, particularly during group assignments, I had the opportunity to collaborate with peers from a wide range of cultural, academic and professional backgrounds. Working alongside individuals from different countries exposed me to varied perspectives, problem-solving approaches, and communication styles. 

One of the most valuable lessons I gained was understanding that everyone has their own way of working. Some prioritise structure and detailed planning, while others thrive in more dynamic and discussion-led environments. Learning to adapt to these differences improved my teamwork, flexibility, and interpersonal skills. 

Beyond academics, engaging with classmates from around the world allowed me to learn about different cultures, values and professional norms. These interactions broadened my worldview and helped me appreciate how business and healthcare practices can vary internationally. 

Importantly, this experience has also given me insight into what to expect when working in a global or cross-cultural professional environment. It has strengthened my confidence in collaborating across borders and prepared me to contribute effectively in international settings. 

Can you share a moment when you felt your studies directly connected to real-world impact or meaningful change? 

One moment when I truly felt my studies connected directly to real-world impact was during a Term 2 lecture in the module Pharma Commercialisation and Marketing. The session focused on how pharmaceutical companies strategically bring a molecule from development to market while ensuring commercial viability. 

Before this lecture, I viewed the pharmaceutical business model as inherently high-risk and uncertain, particularly given the significant investment required in research and development, regulatory approval, and clinical trials. However, the lecture provided valuable insight into the structured strategies companies use to manage these risks. We explored pricing models, market access planning, lifecycle management, competitive positioning, and evidence generation, strategies that support both patient access and commercial sustainability. 

Understanding how companies balance innovation, patient needs, regulatory requirements, and profitability made me appreciate the complexity and sophistication behind pharmaceutical commercialisation. It shifted my perspective from seeing the industry as purely science-driven to recognising it as a highly strategic and value-driven ecosystem. 

What advice would you give someone considering applying to UCL GBSH? 

I would absolutely recommend applying to UCL GBSH to anyone considering it. It has the potential to be one of the most transformative experiences of your academic and personal life. 

The programme challenges you intellectually while also providing countless opportunities for growth beyond the classroom. 

One of the most rewarding aspects is the people you meet. You will connect with students from across the world, each bringing unique perspectives, cultures and experiences. The friendships formed here go far beyond academic collaboration, they become lifelong connections. Being part of such a diverse and ambitious cohort creates an inspiring and motivating environment. 

There are also many memorable moments outside of lectures. From end-of-term celebrations to events held throughout the year, student life at UCL GBSH is vibrant and engaging. Studying in the heart of Queen Elizabeth Olympic Park adds to the experience, providing a dynamic and energetic setting that makes campus life feel truly special. 

Overall, UCL GBSH offers not just an education, but an experience, one that combines academic excellence, global exposure, and undeniable personal growth.